These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8499154)

  • 1. Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen.
    Papac RJ; Keohane MF
    Eur J Cancer; 1993; 29A(7):997-9. PubMed ID: 8499154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complete regression of pulmonary metastases from renal cell carcinoma induced by medroxyprogesterone and streptococcal preparation: a case presentation].
    Nagakura K; Takao M; Matsuzaki S; Ieda K
    Nihon Hinyokika Gakkai Zasshi; 1985 Dec; 76(12):1909-13. PubMed ID: 2940397
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Whitney CW; Brunetto VL; Zaino RJ; Lentz SS; Sorosky J; Armstrong DK; Lee RB;
    Gynecol Oncol; 2004 Jan; 92(1):4-9. PubMed ID: 14751130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
    Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
    Henriksson R; Nilsson S; Colleen S; Wersäll P; Helsing M; Zimmerman R; Engman K
    Br J Cancer; 1998 Apr; 77(8):1311-7. PubMed ID: 9579838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic renal cell carcinoma arising in a congenital solitary kidney. Treatment with interferon-containing combinations. A case report and a review of the literature.
    Merimsky O; Laufer R; Chaitchik S
    J Urol (Paris); 1989; 95(4):243-5. PubMed ID: 2529317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
    Wada T; Yasutomi M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
    [No Abstract]   [Full Text] [Related]  

  • 9. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
    Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
    Matsumoto S; Kutsuna T; Tann M; Mizuno Y; Shinohara M; Kimura T; Banno T; Yoshizaki S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2457-9. PubMed ID: 2526619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.
    Liu JH; Yang MH; Fan FS; Yen CC; Wang WS; Chang YH; Chen KK; Chen PM
    Urology; 2001 Apr; 57(4):650-4. PubMed ID: 11306370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.
    Stahl M; Wilke H; Schmoll HJ; Schöber C; Diedrich H; Casper J; Freund M; Poliwoda H
    Ann Oncol; 1992 Feb; 3(2):167-8. PubMed ID: 1606089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma.
    Wada T; Nishiyama K; Maeda M; Hara S; Tanaka N; Yasutomi M; Kurita T
    Anticancer Res; 1995; 15(4):1581-4. PubMed ID: 7654050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.
    Kokron O; Maca S; Gasser G; Schmidt PR
    Oncology; 1991; 48(2):102-6. PubMed ID: 1997930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
    Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
    Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
    Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].
    Schenck M; Börgermann C; Jäger T; vom Dorp F; Sperling H; Rübben H; Lümmen G
    Urologe A; 2007 May; 46(5):528-34. PubMed ID: 17356836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial.
    Atzpodien J; Kirchner H; Illiger HJ; Metzner B; Ukena D; Schott H; Funke PJ; Gramatzki M; Jürgenson S; Wandert T; Patzelt T; Reitz M
    Br J Cancer; 2001 Oct; 85(8):1130-6. PubMed ID: 11710825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.
    Yang CH; Cheng AL; Yeh KH; Yu CJ; Lin JF; Yang PC
    Cancer; 1999 Aug; 86(3):415-20. PubMed ID: 10430249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.